Zynex Corp (ZYXI) - מזומנים למניה אחת

Zynex, Inc. (ZYXI) generates revenue from the rental and sale of electrotherapy systems for clinics and patients suffering from chronic pain. Medical professionals' trust in the safe NexWave devices strengthens the brand's position in the fight against opioids, while an active R&D cycle and the development of CM-1500 monitors promise breakthrough FDA releases. Cash per share for the issuer demonstrates current liquidity, with 0.00 reflecting the metric's value today.
פילוחי מדדים מקיפים ואנליטיקה עבור Zynex Corp (ZYXI)

Zynex, Inc. (ZYXI) operates under severe pressure from low-cost generics and the risks of shifting medical standards. In such an environment, the liquidity per share calculation determines the business's ability to withstand market volatility without external borrowing. This metric measures the actual safety cushion available to each shareholder for capital protection. Growth in the current cash reserve per share confirms the efficiency of cash flow generation. A stable trend in this indicator guarantees the company's financial stability.